This talk describes the roles of programmed axon death in disease. Blocking it in animal and cell culture models prevents axon degeneration in injury and disease, including glaucoma models. Its aberrant activation causes disease or increases axon vulnerability. There are increasing signs that this occurs in human disease too. The second part of the talk focusses on the well-understood mechanism, its targeting for drug development and the potential for highly effective treatments.
No registration is required.
Join Zoom Meeting: https://nus-sg.zoom.us/j/98111893511?pwd=UUdzM3hpb1ZiWitaVHdRSCt1SUF0UT09
Meeting ID: 981 1189 3511
Subcribe to our mailing list to get the updates to your email inbox...
Best viewed on IE 11, Firefox 27, Chrome 22, and Safari 7 and above.